Joseph K. Belanoff - Jul 31, 2024 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Executive Officer, Director
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Joseph K. Belanoff.
Stock symbol
CORT
Transactions as of
Jul 31, 2024
Transactions value $
-$8,557,575
Form type
4
Date filed
8/2/2024, 04:42 PM
Previous filing
Feb 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $1.48M +450K +129.01% $3.29 799K Jul 31, 2024 Direct
transaction CORT Common Stock Tax liability -$10M -260K -32.5% $38.67 539K Jul 31, 2024 Direct F1
holding CORT Common Stock 2.48M Jul 31, 2024 Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -450K -100% $0.00* 0 Jul 31, 2024 Common Stock 450K $3.29 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on July 31, 2024. The options subject to the net exercise were to expire on February 18, 2025.
F2 Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 01/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
F3 Fully exercisable.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.